Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome

Leukemia Research

Volumn 38, Issue 1, 2014, Pages 95-102

  Chung, Yang Jo ^a   Robert, Carine ^b   Gough, Sheryl M ^a   Rassool, Feyruz V ^b   Aplan, Peter D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

AML; Big Blue mice; MDS; Mutation; NHD13; ROS

Indexed keywords

CD71 ANTIGEN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MOUSE; MUTATION RATE; MYELODYSPLASTIC SYNDROME; NHD13 GENE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSGENE; TRANSGENIC MOUSE;

EID: 84890565361     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.07.008     Document Type: Article

References (50)

1. Rassool F.V., Gaymes T.J., Omidvar N., et al. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia. Cancer Res 2007, 67:8762-8771.
2. Guo W., Keckesova Z., Donaher J.L., et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012, 148:1015-1028.
3. Mijovic A., Mufti G.J. The myelodysplastic syndromes: towards a functional classification. Blood Rev 1998, 12:73-83.
4. Gilliland D.G., Tallman M.S. Focus on acute leukemias. Cancer Cell 2002, 1:417-420.
5. Heaney M.L., Golde D.W. Myelodysplasia. N Engl J Med 1999, 340:1649-1660.
6. Corey S.J., Minden M.D., Barber D.L., Kantarjian H., Wang J.C., Schimmer A.D. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007, 7:118-129.
7. Walter M.J., Shen D., Ding L., et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012, 366:1090-1098.
8. Waris G., Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006, 5:14.
9. Sedelnikova O.A., Redon C.E., Dickey J.S., Nakamura A.J., Georgakilas A.G., Bonner W.M. Role of oxidatively induced DNA lesions in human pathogenesis. Mutat Res 2010, 704:152-159.
10. Slupphaug G., Kavli B., Krokan H.E. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 2003, 531:231-251.
11. Steinboeck F., Hubmann M., Bogusch A., Dorninger P., Lengheimer T., Heidenreich E. The relevance of oxidative stress and cytotoxic DNA lesions for spontaneous mutagenesis in non-replicating yeast cells. Mutat Res 2010, 688:47-52.
12. Themeli M., Petrikkos L., Waterhouse M., et al. Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia. Leukemia 2010, 24:536-543.
13. Sallmyr A., Fan J., Datta K., et al. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood 2008, 111:3173-3182.
14. Koptyra M., Cramer K., Slupianek A., Richardson C., Skorski T. BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 2008, 22:1969-1972.
15. Sattler M., Verma S., Shrikhande G., et al. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000, 275:24273-24278.
16. Farquhar M.J., Bowen D.T. Oxidative stress and the myelodysplastic syndromes. Int J Hematol 2003, 77:342-350.
17. Ghoti H., Amer J., Winder A., Rachmilewitz E., Fibach E. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol 2007, 79:463-467.
18. Novotna B., Bagryantseva Y., Siskova M., Neuwirtova R. Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome. Leuk Res 2009, 33:340-343.
19. Peddie C.M., Wolf C.R., McLellan L.I., Collins A.R., Bowen D.T. Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration. Br J Haematol 1997, 99:625-631.
20. Voukelatou G., Thanopoulou E., Dallas K., et al. CD34+ marrow cells from MDS patients are characterized by higher levels of intracellular reactive oxygen species and inadequate antioxidant defences. Leuk Res 2009, 33:S93-S94.
21. Raza-Egilmez S.Z., Jani-Sait S.N., Grossi M., Higgins M.J., Shows T.B., Aplan P.D. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 1998, 58:4269-4273.
22. Gough S.M., Slape C.I., Aplan P.D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011, 118:6247-6257.
23. Lin Y.W., Slape C., Zhang Z., Aplan P.D. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 2005, 106:287-295.
24. Choi C.W., Chung Y.J., Slape C., Aplan P.D. Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome. Haematologica 2008, 93:1394-1397.
25. Slape C., Liu L.Y., Beachy S., Aplan P.D. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. Blood 2008, 112:2017-2019.
26. Bejar R., Levine R., Ebert B.L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J Clin Oncol 2011, 29:504-515.
27. Chitambar C.R., Massey E.J., Seligman P.A. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide. J Clin Invest 1983, 72:1314-1325.
28. Klebanoff S.J. Myeloperoxidase: friend and foe. J Leukoc Biol 2005, 77:598-625.
29. Low F.M., Hampton M.B., Peskin A.V., Winterbourn C.C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 2007, 109:2611-2617.
30. Kim H., Lee T.H., Park E.S., et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000, 275:18266-18270.
31. Stresing V., Baltziskueta E., Rubio N., et al. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene 2013, 32:724-735.
32. Lee D.C., Mason C.W., Goodman C.B., et al. Hydrogen peroxide induces lysosomal protease alterations in PC12 cells. Neurochem Res 2007, 32:1499-1510.
33. Liu W.S., Baker S.S., Baker R.D., Nowak N.J., Zhu L.X. Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PLoS ONE 2011, 6:e24363.
34. Clopton D.A., Saltman P. Low-level oxidative stress causes cell-cycle specific arrest in cultured cells. Biochem Biophys Res Commun 1995, 210:189-196.
35. Barzilai A., Yamamoto K. DNA damage responses to oxidative stress. DNA Repair 2004, 3:1109-1115.
36. Cuddihy A.R., O'Connell M.J. Cell-cycle responses to DNA damage in G2. Int Rev Cytol 2003, 222:99-140.
37. Huang X., Tran T., Zhang L., Hatcher R., Zhang P. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci U S A 2005, 102:1065-1070.
38. Jakubczak J.L., Merlino G., French J.E., et al. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A 1996, 93:9073-9078.
39. Nowicki M.O., Falinski R., Koptyra M., et al. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004, 104:3746-3753.
40. Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432:316-323.
41. Branzei D., Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol 2008, 9:297-308.
42. Ishikawa K., Ishii H., Saito T. DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 2006, 25:406-411.
43. Puthiyaveetil A.G., Reilly C.M., Pardee T.S., Caudell D.L. Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome. Leuk Res 2013, 37:112-116.
44. Ding L., Ley T.J., Larson D.E., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510.
45. Pinto A.V., Deodato E.L., Cardoso J.S., et al. Enzymatic recognition of DNA damage induced by UVB-photosensitized titanium dioxide and biological consequences in Saccharomyces cerevisiae: evidence for oxidatively DNA damage generation. Mutat Res 2010, 688:3-11.
46. Sanchez-Cespedes M., Parrella P., Nomoto S., et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 2001, 61:7015-7019.
47. Jackson A.L., Chen R., Loeb L.A. Induction of microsatellite instability by oxidative DNA damage. Proc Natl Acad Sci U S A 1998, 95:12468-12473.
48. Zienolddiny S., Ryberg D., Haugen A. Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines. Carcinogenesis 2000, 21:1521-1526.
49. Fan X., Kavelaars A., Heijnen C.J., Groenendaal F., van Bel F. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr Neuropharmacol 2010, 8:324-334.
50. Muvarak N., Nagaria P., Rassool F.V. Genomic instability in chronic myeloid leukemia: targets for therapy. Curr Hematol Malig Rep 2012, 7:94-102.